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1. Introduction 
1.1 Significance of baculovirus-insect cell culture system 
The application of baculoviruses for insect pest management is traced back to the 19th 
century. One of the first reported attempts to use such a virus on an operational scale is the 
introduction of a multinucleocapsid nucleopolyhedroviruses (MNPV) into the populations 
of the nun moth, Lymantria monacha in Germany in 1892. Natural agents were used for 
controlling the insects in ancient China. For expample, pharoah’s ants in barns were used to 
combat destructive insects. Chemical insecticides have been widely used in agriculture due 
to their strong toxicity to insects. Massive and long term use of chemical insecticides should 
be avioded because they not only are harmful to human health, but also contaminate water 
and soil. Viral pesticides are continuously studied and developed and the advantages of 
using baculoviruses in pest management programs are generally recognized. The important 
attribute of baculoviruses for pest control is their host-specificity. In most cases, only a few 
insect species from the same family or the same genus are susceptible to a given virus 
(Ignoffo, 1968). No member of the baculovirus family has ever been isolated from a host 
other than an arthropod. In addition, viral insecticides do not create resistance problems in 
either target or non-target species and they do not show cross-resistance with chemical 
compounds. A further advantage of using viruses is that they do not create residue 
problems. They neither accumulate in food chains, nor interact with other pesticide 
residues. In short, they do not create the problems associated with the use of many chemical 
insecticides (Primentel et al., 1980). Insect viruses are ideally suited for integration with most 
other plant protection measures used in integrated pest management (IPM) programs. 
In spite of the obvious advantages of viral insecticides over chemical pesticides, the former 
are scantly used. It has been estimated that baculoviruses are capable of replacing 80% of the 
chemical insecticides currently used in agricultural applications. Nevertheless, Helicoverpa 
armigera single nucleocapsid nucleopolyhedrovirus (HaSNPV) has been adopted for mass 
production as a viral pesticide and has been widely used to control the insect pests in China 
(Zhang et al., 1995) and in other countries (Jones, 1994) as well. Since 1993 the first HaSNPV 
pesticide was registered in China. It is estimated that in the last ten years, the annual output 
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of HaSNPV was about 200-300 tons, enough to treat about 100,000 ha of cotton. H. zea single 
nucleocapsid NPV (HzSNPV) was registered as one of the first commercial baculovirus 
pesticides (Viron-H, Biocontrol-VHZ, ElcarTM) in the 1970s and has been extensively used to 
control the cotton bollworm in the USA and other countries (Shieh, 1989). HaSNPV has been 
successfully used to manage heliothine pests, such H. armigera and H. assulta, that are 
resistant to chemical insecticides and Bt toxin (Zhang, 1989). 
The significance of the baculovirus-insect cell culture system has become increasingly 
evident since many methods have been developed to construct recombinant baculoviruses 
(Davies, 1994). On this account, there are incentives and advantages for studying this 
system. Firstly, baculovirus expression systems frequently give high level expression of 
proteins with full biologicals activity. This combination of highly desirable features is 
responsible for the widespread popularity of baculovirus expression systems and therefore 
insect cell cultures offer an attractive for manufacturing of pharmaceuticals, biologicals, etc. 
Secondly, this system has an additional interest in application of baculoviruses as biological 
insecticide. Considerable effort has been made to enhance the insecticidal potency of 
baculoviruses by introducing foreign genes, such as hormones or toxins, to the viral genome 
(Wood & Granados, 1991; Bonning & Hammock, 1992). 
Baculoviruses have proven to be an efficient agent for control of insect pests (Bonning & 
Hammock, 1992). In addition to this, they can be used efficiently for the production of 
recombinant proteins by genetic engineering manipulation (Mariorella et al., 1988; Davies, 
1994; Kitts, 1996). There is a strong interest in the development of large-scale processes for 
bio-pesticide production based on the cultivation of insect cells and subsequent infection 
with baculoviruses. This requires the design and optimization of bioreactors of relatively 
large volume, and the optimization of their operation strategy. Mathematical modeling has 
been an important tool in this task (de Gooijer et al., 1989; 1992; Kumar & Shuler, 1995; 
Power & Nielsen, 1996). 
1.2 Bacloviruses 
Baculoviruses comprise a large group of viral pathogens of arthropods, particularly of 
insects of the orders Lepidoptera, Hymenoptera and Diptera. Over 600 species of insects 
were susptible to baculoviruses. Viral isolates usually infect only a single or a few related 
species of insects. 
The family Baculoviridae consists of a single genus, Baculovirus, which is divided into two 
subgroups based on their morphology. Subgroup a viruses, the nucleopolyhedroviruses 
(NPVs), produce virions which have either a single nucleocapsid per envelope (single-
nucleocapsid nuclear polyhedrosis virus, SNPV) or one to many nucleocapsids per envelope 
(multinucleocapsid nucleopolyhedroviruses, MNPV). Occlusion bodies (OB), i.e. occluded 
viruses (OVs), called polyhedra due to their crystalline shape appearance in the light 
microscope, which protect the virions from rapid environmental decay, form in the nucleus 
of NPV-infected cells. Many enveloped nucleocapsids (virions) are embedded in each OB. 
Subgroup B viruses, the granulosis viruses (GVs), contain only one nucleocapsid per 
envelope and asingle virion per OB where it is called Granula (Blissard, 1996). The main 
characteristic of baculoviruses of both subgroups A and B is that crystalline OBs containing 
occluded virus particles form in the nuclei of infected cells. The major protein of  OBs, called 
polyhedrin or granulin, accounts for approximately 95% of the protein of OBs. 
Baculoviruses from subgroups A and B are large, enveloped viruses with a double-stranded 
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circular DNA genome ranging in size from 80 to 200 kilobase pairs (kbp). They are named 
baculoviruses due to the rod-shaped nucleocapsids. 
1.2.1 In vivo infection and replication of baculoviruses  
The multiplication of baculoviruses in vivo is a complex and highly ordered process. The 
replication of AgMNPV in midgut epithelial cells is divided into three phases. In phase I (1 
to 4 hr p.i.), the infection starts with the food contaminated with occluded viruses and their 
dissolution in the insect midgut due to the action of the highly alkaline digestive juices (pH 
9.5 to 11.5) and possibly some enzymatic degradation also. The released virions are able to 
penetrate the peritrophic membrane and enter the epithelial cells of the midgut by fusion 
with the microvillus membrane and are transported into cell nucleus where uncoating of the 
viral genome occurs. Phase II (8 to 12 hr p.i.) represents the replicative stage where virogenic 
stroma give rise to enveloped nucleocapsids. Other nucleocapsids are released into 
cytoplasm by means of vesicles originating from the nuclear envelope. In final phase III ((14 
to 24 hr p.i.) generally virus-free OBs are produced. In addition, nucleocapsids are released 
from the vesicles and they acquire an envelope by budding through the plasma membrane 
and the basal lamina. The budded nonoccluded virus (NOV or BV) possesses a peplomer 
structure and is responsible for secondary infection within the host insect blood. 
The extracellular nonoccluded virus may infect blood cells and other tissues, such as trachea 
and fat body, where the infection process is repeated. Alternatively, blood cells may invade 
these tissues and transmit the infection by cell-to-cell contact (Keddie et al., 1989). Early after 
infection of cells of these tissue, NOVs are produced to vector the infection systemically. 
Later after infection, NOV production ceases and is followed by the assembly of 
nucleocapsids in the nucleus into de novo systhesized membranes and occlusion of these 
virions (OVs) into polyhedra. Nuclei of infected cells from the various tissues become filled 
with polyhedra. Thus, two infectious froms of the virus (NOVs and OVs), which are 
phenotypically different but genetically identical, are produced during baculovirus 
infection. 
1.2.2 In vitro infection and replication of baculoviruses 
The replication of baculoviruses in cell culture (in vitro) is similsr to the events occurring in 
vivo. However, in contrast to OV, which enters cells by direct fusion at the plasma 
membrane, NOV (BV) enters cells by endocytosis. After the uptake of the virion into an 
endocytic vesicle, membrane fusion must occur before releasing the nucleocapsid into the 
cytoplasm. The nucleocapsids are transported to the nucleus where they are uncoated and 
the viral DNA is transcribed and replicated. During this period syntheses of host 
macromoleculars are shut down with concomitant rearrangement of the cytoskeleton, such 
as disappearance of condensed chromatin. Prgeny DNA is filled into nucleocapsids. At this 
point, the two viral types begin to emerge in the infection process. Those virions that are 
destined to become occluded (OVs) remain in the nucleus, and they gain an envelope. In 
contrast, NOVs escape the nucleus possibly by budding through the inner nuclear 
membrane and migrate to the plasma membrane (Raghow & Grace, 1974; Hirumi et al., 
1975; Knudson & Harrap, 1976). By the time they reach the plasma membrane, they are 
unenveloped nucleocapsids, having lost nuclear membrane remnants in transit. These 
nucleocapsids bud from plasma membrane into the medium, acquiring an envelope with 
apikes and resulting in virions composed of single nucleocapsids per envelope. The process 
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of budding starts at 10-12 h p.i. and completes around 24 h p.i., and the NOV production is 
discontinued after the appearance of polyhedra (Volkman, et al., 1976). The assembled 
virions are then, in turn, occluded into newly-emerging polyhedra. Finally, the cell and 
nucleus lyses, releasing the polyhedra that represent about 30% of the biomass of infected 
cells and this is the objective of the production of recombinant proteins using this system. In 
terms of the timing of infection process, the infection cycle of wild-type baculovirus can be 
divided into three phases: early (0 to 6 h p.i.), late (8 to 18 h p.i.), and very late (20 to 72 h 
p.i.) (Miller, 1988). The late phase is characterized by the synthesis of NOVs being capable of 
budding from the surface. The very late phase is characterized by the embedding of virions 
in occlusion bodies. 
The cytopathic effect that accompanies viral replication is clearly observed with a light 
microscope. Initial signs of infections in the microscope are a general rounding of the cells, a 
swelling of the nucleus with a concomitant disappearance of condensed chromatin and the 
emergence of a defined stippled area, i.e. the virogenic stroma. These signs are evidences to 
determine which cells are infected when making viral titer of samples. 
1.3 Factors affecting baculovirus-insect cell culture system 
In vitro infection of insect cells with baculoviruses is increasingly considered as a viable 
means for the production of biopesticides, recombinant veterinary vaccines and other 
recombinant products (Atkinson et al., 1990). Over the last two decades, much effort has 
been focused on identifying factors that affect the productivities of such expression systems, 
including the cell line (Wickham et al., 1995), medium (Caron et al., 1990), oxygen supply 
(Gotoh et al., 2002), reactor design (Rice et al., 1993; Zhang et al., 1993) and infection 
strategy, which involves the multiplicity of infection (MOI), time of infection (TOI), initial 
cell density (ICD) and medium replacement (Carinhas et al., 2009; Hu and Bentley, 2001; 
Radford et al., 1997; Rodas et al., 2005; Yamaji et al., 1999; Zhang et al., 2005).  
Batch processes usually employ intermediate to high MOIs in the exponential phase of 
growth, which result in synchronous infection of the insect cells and optimal yields of 
recombinant products or of polyhedra as bioinsecticides (Kumar et al., 1995). A recent study 
regarding the production of budded viruses (BVs) using a high MOI demonstrated that 
medium replacement at the time of infection considerably improved BV production, which 
increased with the cell concentration and reached a virus titer of 2.6×1010 infectious particles 
(IPs) per mL in cultures of 3.5×106 Sf9-infected cells per mL (Carinhas et al., 2009). However, 
the use of such complex mixtures would involve higher operation costs and lead to 
variability in the process performance (Carinhas et al., 2009). In the case of high MOIs and 
higher cell densities, the technology for BV or recombinant protein production becomes 
more complex. However, the use of a low MOI has been proposed for three major reasons 
(Enden et al., 2005; Maranga et al., 2003; Wong et al., 1996; Zhang et al., 2005) as follows: (1) 
at the industrial production scale, the virus inoculum has to come from a certified and costly 
master bank, and use of a low MOI will increase the lifespan of the master bank; (2) if a low 
MOI is used, it is not necessary to replace spent medium with virus stock added into the 
bioreactor, which potentially interferes with the process performance; (3) if a low MOI is 
used, the problem of the “passage effect” will be minimized. The main consideration for this 
approach is that inoculation of the viral stock can be carried out directly from a well-
characterized master bank into a single scaled-up bioreactor. Furthermore, it has been 
reported that the maximum product titers were lower for a high MOI than for a low MOI 
after infection in the early exponential growth phase (Hu & Bentley, 2001; Zhang et al., 
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2005). Among all the factors that affect the productivities of insect cell-recombinant 
baculovirus expression systems, such as the cell line, medium, oxygen supply, bioreactor 
design and infection strategy involving the MOI, TOI, ICD and medium replacement, the 
medium, oxygen supply and bioreactor design are relatively fixed for a given expression 
system, but the infection strategy is relatively uncertain and can be manipulated. More 
specifically, the interplay among the MOI related to the number of IPs per cell, TOI related 
to the cell state and cell cycle distribution and ICD affecting the cell concentration at the TOI 
is of the utmost importance for the design of efficient infection strategies. To date, the 
relationships among the MOI, TOI and ICD have not been understood at the theoretical 
level. Quantitatively, orthogonal designs have been widely used to investigate the factors 
that influence each other in many fields, but the literature related to investigations of the 
MOI, TOI and ICD for insect cell-recombinant expression systems using orthogonal designs 
is scarce. To avoid the complexity of the technology associated with large scale productions, 
high MOIs and medium replacement are not considered to be factors that can be 
investigated by orthogonal designs. The purpose of the present study was to investigate the 
quantitative relationships among the TOI, ICD and low MOI and optimize the infection 
strategy for such expression systems using an orthogonal design.  
2. Materials and methods 
2.1 Stocks of cells  
Heliothis zea HzAM1 cells were provided by Dr. Hualin Wang from the Wuhan Institute of 
Virology, Chinese Academy of Sciences (Wang et al., 2008). The cells were maintained at 
27°C in 25-cm2 T-flasks in Grace’s medium, comprising Grace’s insect medium 
supplemented with 1% Yeastolate Ultrafiltrate (Gibco), 1.5% chemically defined Lipid 
Concentrate (Gibco) and 5% fetal bovine serum (Gibco) (unpublished in English). The cells 
were routinely subcultured every 3–4 days.  
2.2 Cell culture 
HzAM1 cells were inoculated into 100-mL glass Erlenmeyer flasks containing 20 mL of 
medium supplemented with 0.2% Pluronic F-68 (Gibco), and cultured with shaking at 80 
rpm. Suspension cultures of HzAM1 cells were collected daily for cell counting in a 
hemocytometer and cell viability determination by Trypan Blue staining exclusion using a 
0.4% (w/v) solution (Sigma). 
2.3 Virus stock and bioassay 
A recombinant HaSNPV incorporating the green fluorescent protein (GFP) gene 
(HaBacHZ8-eGPF-PH) was constructed and kindly provided by Dr. Hualin Wang from the 
Wuhan Institute of Virology, Chinese Academy of Sciences (Jing et al., 2008; Pan et al., 2007). 
HzAM1 cells infected with this recombinant virus expressed GFP and were easy to detect 
under a fluorescence light microscope (BX-51; Olympus) (Cha et al., 1997). For propagation 
of HaSNPV, HzAM1 cells at a density of 2×106 cells mL-1 in T-flasks were infected with the 
recombinant baculovirus at MOIs of 2–5 and harvested at 72 h after infection. The infectivity 
of BVs was measured using the end-point dilution method, and expressed as the 50% tissue 
culture infective dose (TCID50) (Nielsen et al., 1992; Reed & Muench, 1938). The TCID50 was 
calculated according to Spearman and Karber (Finney, 1978). Samples were centrifuged at 
10,000 × g for 1 min, and the supernatants and cell pellets were stored at –70°C and 4°C, 
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respectively, until analysis. For counts of occluded viruses (OVs), the pellets were treated 
with an equal volume of 2% SDS solution for 1 h at room temperature. Duplicate samples 
were homogenized and the numbers of OVs or polyhedra were counted in the central 
square of a hemocytometer under a light microscope (BX-51; Olympus).  
2.4 Experimental protocol 
Shaking cultures were performed in duplicate in 100-mL shake-flasks containing 20 mL of 
cell suspension solution with shaking at 80 rpm. The temperature was maintained at 27°C. 
Controls comprised cell cultures without virus infection. For the HzAM1 cell-recombinant 
virus system, the MOI, TOI and ICD in the shaking cultures were evaluated using an 
orthogonal design. The ICD was defined as the cell density when the cells were inoculated 
into the cultures, and not when the cells were infected. The TOI was defined as the time of 
infection. The TOIs investigated in the present study were the early, middle and late 
exponential phases, and the time periods of the cultures differed for different ICDs (Kioukia 
et al., 1995). The variable assignments and level settings in the orthogonal array design are 
listed in Table 1. The variable assignments, level settings and experimental arrangements in 
the orthogonal array design are shown in Tables 2 and 3. A total of nine experiments are  
 
Levels 
Factors 
MOI  
(TCID50.cell-1) (A) 
ICD 
 (105 cells.mL-1) (B) 
TOI  
(h) (C) 
1 0.01 1.0 Early exponential phase 
2 0.1 3.0 Middle exponential phase 
3 1.0 2.0 Late exponential phase 
Table 1. Variable assignments for the MOI, ICD and TOI and the level settings 
 
Factors
 
Experiment  
number 
MOI 
(TCID50.cell-1) 
(A) 
ICD 
(105 cells.mL-1) 
(B) 
TOI  
(h) (C) 
Maximum titer 
of BV 
(105 TCID50.mL-
1) 
1 1 1 1 2.00 
2 1 2 2 28.00 
3 1 3 3 9.28 
4 2 1 2 20.00 
5 2 2 3 92.8 
6 2 3 1 200.00 
7 3 1 3 6.32 
8 3 2 1 6.32 
9 3 3 2 13.30 
K1(105 TCID50.mL-1) 13.09 9.44 69.44  
K2(105 TCID50.mL-1) 104.27 42.37 20.43  
K3(105 TCID50.mL-1) 8.65 74.19 36.13  
R(105 TCID50.mL-1) 95.62 64.75 49.01  
Table 2. Effects of the MOI, ICD and TOI on the BV titer 
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Factors
Experiment  
number 
MOI  
(TCID50.cell-1) 
(A) 
ICD 
(105 cells.mL-1) 
(B) 
TOI  
(h) (C) 
Maximum OV 
concentration 
(104 OV.mL-1) 
1 1 1 1 110 
2 1 2 2 120 
3 1 3 3 125 
4 2 1 2 145 
5 2 2 3 160 
6 2 3 1 190 
7 3 1 3 125 
8 3 2 1 142 
9 3 3 2 160 
K1’ (104 OVs.mL-1) 118 127 147  
K2’ (104 OVs.mL-1) 165 141 142  
K3’ (104 OVs.mL-1) 142 158 137  
R’ (104 OVs.mL-1) 47 32 11  
Table 3. Effects of the MOI, ICD and TOI on the OV concentration 
listed in the trial columns. The numbers 1, 2 and 3 under the various column numbers in the 
tables represent the level settings in the experiments. The Km or Km’ (m=1–3) values and the 
R or R’ values in the last four rows of Tables 2 and 3 are the average responses, i.e., BVs or 
OVs with variable m, and the differences between the maximum and minimum values with 
variable m, respectively. The Km or Km’ values were used to estimate the effects of the 
variable and the R or R’ values were used to evaluate the sensitivity of the variable to the BV 
titer or OV concentration.  
3. Results 
After implementing the nine experimental trials designed according to the L9(34) orthogonal 
array shown in Table 2, with sampling for measurements of the BV titer and OV 
concentration every 12 h and the cell density every 24 h, the output responses for each 
experimental trial were calculated (Tables 2 and 3). As shown in the last column of Table 2, 
the maximum BV titer of 2.00×107 TCID50 mL-1, equivalent to 9.2×109 IPs mL-1 (1 TCID50 mL-1 
= 460 IPs mL-1, based on flowcytometry analysis and the end-point dilution method; data 
not shown), was obtained for the condition of A2B3C1. Furthermore, the optimal conditions 
for that experiment were also A2B3C1, as evaluated by analyzing the Km values, i.e., the 
average responses at each of the three levels. These results indicated that the optimal 
conditions for BV production in the suspended HzAM1 cell-recombinant virus system were 
inoculation of the suspended cells at an ICD of 2.0×105 cells mL-1 and a MOI of 0.1 when the 
cells were at the early exponential growth phase. As shown in the last column of Table 3, the 
maximum OV concentration of 1.9 ×106 OVs mL-1 was obtained for the condition of A2B3C1. 
Furthermore, the optimal conditions for that experiment were also A2B3C1, as evaluated by 
analyzing the Km’ values. Consequently, the optimal conditions for OV production were the 
same as those for BV production in the suspended HzAM1 cell-recombinant virus system. 
These findings are logically reasonable and indicate that BVs and OVs are closely related, 
representing only two different virion phenotypes. 
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Fig. 1 shows the evolution of the unstained cell concentration for the ICDs of 1.0×105, 
2.0×105 and 3.0×105 cells mL-1, and in a control experiment. The data indicated that the 
maximum unstained cell concentration, decrease in growth rate upon infection, time of 
onset of a decrease in the unstained cell concentration and the decrease drop rate were 
dependent on not only the ICDs, but also the TOIs and MOIs (Fig. 1a–c). Since the large 
change in the BV concentration requires logarithmic presentation of the data and the 
primary data were obtained as the negative logarithm of the TCID50 [-log(TCID50)], and the 
error of the method is estimated in the logarithmic scale and not easily translated into linear 
units, the evolution of the number of BVs was calculated in the form of -log(TCID50) (Zhang 
et al., 2005). Fig. 2 shows the evolution of the -log(TCID50) for the ICDs of 1.0×105, 2.0×105 
and 3.0×105 cells mL-1. The errors of all the sample analyses ranged from 0% to 5% and are 
not indicated in Fig. 2. The maximum value of the -log(TCID50) was 6.0 (Fig. 2b, compare 
with Fig. 2a and c) and the corresponding BV value was 2.0×107 TCID50 mL-1 in the case of 
an ICD of 2.0×105 cells mL-1, a MOI of 0.10 and a TOI at the early exponential phase. These 
represent the best results obtained for the HzAM1 cell-recombinant baculovirus system, 
based on comparisons with previously reported data (McIntosh et al., 2001; Wang et al., 
2008). Fig. 3 shows the evolution of the amount of OVs for the ICDs of 1.0×105, 2.0×105 and 
3.0×105 cells mL-1. The errors of all the sample analyses ranged from 0% to 5% and are not 
indicated in Fig. 3. The maximum OV concentration of 1.9×106 OVs mL-1 compared with 
those in Fig. 3a and c was obtained for an ICD of 2.0×105 cells mL-1, a MOI of 0.10 and a TOI 
at the early exponential phase. 
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Fig. 1. Evolution of the unstained cell concentration for the ICDs of 1.0×105 cells mL-1 (a), 
2.0×105 cells mL-1 (b) and 3.0×105 cells mL-1 (c) and in a control experiment. Arrows indicate 
the times when the viruses were added to the cultures. 
c) 
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Fig. 2. Evolution of the minus logarithm of the TCID50 for the ICDs of 1.0×105 cells mL-1 (a), 
2.0×105 cells mL-1 (b) and 3.0×105 cells mL-1 (c). The errors of all the sample analyses ranged 
from 0% to 5% and are not indicated in the panels. 
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Fig. 3. Evolution of the amount of OVs for the ICDs of 1.0×105 cells mL-1 (a), 2.0×105 cells 
mL-1 (b) and 3.0×105 cells mL-1 (c). The errors of all the sample analyses ranged from 0% to 
5% and are not indicated in the panels. 
www.intechopen.com
 
Optimization of the Strategy for Recombinant Baculovirus Infection of Suspended Insect Cells 
 
153 
4. Discussion 
4.1. Optimization of the MOI for BV and OV productions 
The effects of the MOI on the BV titer and OV concentration at three different levels as factor 
A are shown in Tables 2 and 3. It can be seen from Table 2 that the Km (m=1–3) values 
corresponding to the MOIs were 1.309×106, 1.0427×107 and 8.65×105 TCID50 mL-1, which 
represent the average BV response values at the three MOIs of 1.0, 0.10 and 0.01, 
respectively, and reflect the effects of the MOI on BV production. The maximum value, K2, 
was 1.0427×107 TCID50 mL-1 at a MOI of 0.10. The difference between the maximum value K2 
and the minimum value K3, i.e., the R value corresponding to the MOI, was 9.56×106 TCID50 
mL-1, which is higher than the other R values of 6.48×106 and 4.90×106 TCID50 mL-1 
corresponding to the ICD and TOI, respectively. These findings indicate that the sensitivity 
of the MOI to the BV titer is highest when a low MOI is used. In the same way, it can be seen 
from Table 3 that the Km’ (m=1–3) values corresponding to the MOIs were 1.18×106, 1.65×106 
and 1.42×106 OVs mL-1, which represent the average OV response values at the three MOIs 
of 1.0, 0.10 and 0.01, respectively, and reflect the effects of the MOI on OV production. The 
maximum value, K2’, i.e., the optimal condition, was achieved at a MOI of 0.10, indicating 
that the optimal MOI for OV production was the same as that for BV production. The 
difference between the maximum value K2’ and the minimum value K1’, i.e., the R’ value 
corresponding to the MOI, was 4.7×105 OVs mL-1, which is higher than the other R values of 
3.2×105 and 1.1×105 OVs mL-1 corresponding to the ICD and TOI, respectively. These 
findings indicate that the sensitivity of the MOI to the OV concentration is highest when a 
low MOI is used. Therefore, it is concluded that the MOI has relatively significant influences 
on the BV titer and OV concentration when a low MOI is used. Furthermore, it can be seen 
from the data for the 9 experiments shown in the last columns of Tables 2 and 3 that both the 
maximum BV titer and maximum OV concentration were produced at A2, i.e., a MOI of 0.10. 
4.2 Optimization of the ICD for BV and OV productions 
The effects of the ICD on the BV titer and OV concentration at three different levels as factor 
B are shown in Tables 2 and 3. It can be seen from Table 2 that the Km (m=1–3) values 
corresponding to the ICDs were 9.44×105, 4.24×106 and 7.42×106 TCID50 mL-1, which 
represent the average BV response values at the three levels of ICD, respectively, and reflect 
the effects of the ICD on BV production. The maximum value, K3, was 7.419×106 TCID50 mL-
1 at the ICD of 2.0×105 cells mL-1. The difference between the maximum value K3 and the 
minimum value K1, i.e., the R value corresponding to the ICD, was 6.48×106 TCID50 mL-1, 
which is higher than 4.90×106 TCID50 mL-1 corresponding to the TOI, but smaller than 
9.56×106 TCID50 mL-1 corresponding to the MOI. These findings indicated that the sensitivity 
of the ICD to the BV titer is not high (as described above). In addition, it can be seen from 
Table 3 that the Km’ (m=1–3) values corresponding to the ICDs were 1.27×106, 1.41×106 and 
1.58×106 OVs mL-1, which represent the average OV response values at the three levels of 
ICD, respectively, and reflect the effects of the ICD on OV production. The maximum value, 
K3’, i.e., the optimal condition, was achieved at an ICD of 2.0×105 cells mL-1, indicating that 
the optimal ICD for OV production was the same as that for BV production. Furthermore, it 
can be seen from the data for the nine experiments shown in the last columns of Tables 2 
and 3 that both the maximum BV titer and maximum OV concentration were produced at 
B3, i.e., an ICD of 2.0×105 cells mL-1. 
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4.3 Optimization of the TOI for BV and OV productions 
The effects of the TOI on the BV titer and OV concentration at three different levels as factor 
C are shown in Tables 2 and 3. It can be seen from Table 2 that the Km (m=1–3) values 
corresponding to the TOIs were 6.94×106, 2.04×106 and 3.61×106 TCID50 mL-1, which 
represent the average BV response values at the three levels of TOI, respectively, and reflect 
the effects of the TOI on BV production. The maximum value, K1, was 6.94×106 TCID50 mL-1 
at the early exponential phase. The difference between the maximum value K1 and the 
minimum value K2, i.e., the R value corresponding to the TOI, was 4.9×106 TCID50 mL-1, 
which is the smallest among the three R values (as described above), indicating that the TOI 
has a weak influence on BV production when a low MOI is used. In addition, it can be seen 
from Table 3 that the Km’ (m=1–3) values corresponding to the TOIs were 1.47×106, 1.42×106 
and 1.37×106 OVs mL-1, which represent the average OV response values at the three TOIs, 
respectively, and reflect the effects of the TOI on OV production. The maximum value, K1’, 
i.e., the optimal condition, was achieved at the early exponential phase, indicating that the 
optimal TOI for OV production was the same as that for BV production. Furthermore, it can 
be seen from the data for the 9 experiments shown in the last columns of Tables 2 and 3 that 
both the maximum BV titer and maximum OV concentration were produced at C1, i.e., at 
the early exponential phase. 
4.4 Effects of the MOI, ICD and TOI on BV and OV productions 
The effects of the MOI, ICD and TOI on BV and OV productions can be seen from the R and 
R’ values (Tables 2 and 3), which were used to evaluate the sensitivity of each variable to the 
BV titer or OV concentration. The R values corresponding to the MOI, ICD and TOI were 
9.56×106, 6.48×106 and 4.90×106 TCID50 mL-1, respectively, indicating that the MOI has the 
most significant influence on BV production, followed by the ICD and finally the TOI in the 
HzAM1 cell-recombinant baculovirus system when a low MOI is used. Furthermore, the R’ 
values corresponding to the MOI, ICD and TOI were 4.7×105, 3.2×105 and 1.1×105 OVs mL-1, 
respectively, demonstrating similar effects of the MOI, ICD and TOI on OV production 
compared with BV production. As stated above, the optimal conditions for both BV 
production and OV production in the HzAM1 cell-recombinant baculovirus system were a 
MOI of 0.10, an ICD of 2.0×105 cell mL-1 and a TOI at the early exponential phase.  
With respect to the MOIs of 1.0, 0.10 and 0.01, most of the HzAM1 cells were likely to be 
infected at a MOI of 1.0 at the early exponential phase because more viruses were added to the 
culture compared with the MOIs of 0.10 and 0.01, and as a result, there were insufficient 
uninfected cells to propagate for infection at later time points with viruses generated during 
the ‘primary infection process’ (Kioukia et al., 1995; Zhang et al., 2005). As shown in Fig. 1c, the 
unstained cell concentration showed a sharp decrease at 72 h after the inoculation when the 
cells were infected at a MOI of 1.0 at 24 h, i.e., the early exponential phase. Therefore, the 
numbers of BVs and OVs produced would exhibit lesser increases in the secondary and 
tertiary infections when a MOI of 1.0 was used at the early exponential phase as shown in Figs. 
2c and 3c. Conversely, if the HzAM1 cells were infected at a MOI of 0.01 at the early 
exponential phase, fewer cells would be infected and the number of viruses generated in the 
primary infection process would be lower. It is possible that most of the uninfected cells and 
their progeny would not be infected before the cells entered into the stationary phase or death 
phase as shown in Fig. 1a, indicating that these cells would not play a role in virus replication 
because of their weak physiological state. Therefore, the maximum BV and OV productions 
were not obtained when the cells were infected at MOIs of 0.01 (Figs. 2a and 3a) and 1.0 (Figs. 
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2c and 3c) at the early exponential phase. However, the number of cells infected was likely to 
be suitable for later infection cycles when the MOI was 0.1, which resulted in the maximum 
productions of BVs (Fig. 2a–c) and OVs (Fig. 3a–c). The evolution of unstained cells (Fig. 1) and 
the dynamics of BVs (Fig. 2) and OVs (Fig. 3) at a MOI of 0.1 were very complicated and 
similar to those in our previous studies (Enden et al., 2005; Zhang et al., 2005), and are thus not 
elaborated upon in this paper. With respect to the three ICDs, when the ICD was 1×105 cells 
mL-1, the remaining uninfected cells would be too few to propagate for infection in later 
infection cycles compared with the ICDs of 2×105 and 3×105 cells mL-1. However, when the 
ICD was 3×105 cells mL-1, the remaining uninfected cells would be too many to propagate for 
infection in later infection cycles compared with the ICDs of 1×105 and 2×105 cells mL-1. These 
extra cells would be likely to proliferate vigorously in the early exponential phase, and as a 
result, the nutrient components in the culture would be consumed too early and too rapidly 
for subsequent infection cycles. This means that the physiological environment in the culture 
would deteriorate and have no benefit for the uninfected cells and their progeny to be infected 
with BVs during the later infection process. Therefore, the cells at the ICDs of 1×105 cells mL-1 
(see Figs. 2a and 3a) and 3×105 cells mL-1 (see Figs. 2c and 3c) infected at a MOI of 0.1 would 
not reach the maximum amounts of BVs and OVs, whereas the cells infected at an ICD of 
2×105 cells mL-1 would reach the maximum amounts of BVs and OVs (see Figs. 2b and 3b). 
With respect to the TOI (early, middle or late exponential growth phase), the cells infected at a 
low MOI at the early exponential growth phase achieved a longer period of culture with the 
added viruses and their progeny viruses (BVs) to create more infection cycles before the cells 
entered the stationary phase or death phase compared with the cells infected at the middle and 
late exponential growth phases. This is probably an important reason why better effects on the 
amounts of BV and OV productions were observed when infection was carried out at the early 
exponential growth phase (see Figs. 2b and 3b). The interplay among the MOI, TOI and ICD in 
the HzAM1 cell-recombinant baculovirus system has not been understood at the theoretical 
level. Currently, our research is focusing on the relationships of the cell cycle phases and cell 
cycle distributions with virus infection using a synchronization method and flow cytometry, 
with further attempts to understand the relationships between the amounts of viruses 
produced and the cell states when infected. 
In conclusion, to avoid the complexity of the technology associated with large scale 
production, high MOIs and medium replacement were not considered as factors to be 
investigated in our studies. An orthogonal design was applied to select the optimum 
conditions, in which the effects of the MOI, ICD and TOI on the productions of BVs and OVs 
were evaluated in the HzAM1 cell-recombinant baculovirus system. The results indicated that 
among the MOI, TOI and ICD, the MOI had relatively significant influences on the amounts of 
BVs and OVs produced at a low MOI. The optimal conditions for both BV and OV productions 
in the HzAM1 cell-recombinant baculovirus system were a MOI of 0.10, an ICD of 2.0×105 cells 
mL-1 and a TOI at the early exponential phase. These findings are logically reasonable and 
indicate that BVs and OVs are closely related, representing only two different virion 
phenotypes. Virus titers as high as 2.0×107 TCID50 mL-1, equivalent to 9.2×109 IPs mL-1, were 
obtained without medium replacement at a low MOI, which represent the best results 
obtained for the HzAM1 cell-recombinant baculovirus system, based on comparisons with 
previously reported data (McIntosh et al., 2001; Wang et al., 2008). Overall, the present data 
demonstrate that high titers can be obtained at a low MOI and that the technology required for 
this bioprocess was shortened by an efficient orthogonal design. Furthermore, the interplay 
among the MOI, TOI and ICD was elucidated. 
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Second section provides recent information on biomarkers currently used to evaluate pesticide exposure,
effects, and genetic susceptibility of a number of organisms. Some antioxidant enzymes and vitamins as
biochemical markers for pesticide toxicity are examined. The inhibition of the cholinesterases as a specific
biomarker for organophosphate and carbamate pesticides is commented, too. The third book section
addresses to a variety of pesticides toxic effects and related issues including: the molecular mechanisms
involved in pesticides-induced toxicity, fish histopathological, physiological, and DNA changes provoked by
pesticides exposure, anticoagulant rodenticides mode of action, the potential of the cholinesterase inhibiting
organophosphorus and carbamate pesticides, the effects of pesticides on bumblebee, spiders and scorpions,
the metabolic fate of the pesticide-derived aromatic amines, etc.
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